Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells

Brain tumor glioblastoma is one of the worst types of cancer. The blood–brain barrier prevents drugs from reaching brain cells and shields glioblastoma from treatment. The creation of nanocarriers to improve drug delivery and internalization effectiveness may be the solution to this issue. In this p...

Full description

Bibliographic Details

Published in:	Molecules
Main Authors:	Albina Y. Ziganshina, Elina E. Mansurova, Alexandra D. Voloshina, Anna P. Lyubina, Syumbelya K. Amerhanova, Marina M. Shulaeva, Irek R. Nizameev, Marsil K. Kadirov, Leysan R. Bakhtiozina, Vyacheslav E. Semenov, Igor S. Antipin
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Subjects:	glioblastoma doxorubicin nanocarrier uracil thymine diallyl disulfide
Online Access:	https://www.mdpi.com/1420-3049/28/2/551